Tzu-Fei Wang
MD, MPH
Clinician Scientist, Inflammation and Chronic Disease
Ottawa Hospital Research Institute
Associate professor, Division of Hematology
Department of Medicine
Bio
Tzu-Fei Wang, MD, MPH is a hematologist and an associate professor in the Division of Hematology, Department of Medicine at the University of Ottawa and the Ottawa Hospital and a Scientist at the Ottawa Hospital Research Institute. Her main areas of clinical and research interest include clinical research for the optimal prevention and treatment strategies for patients with cancer-associated thrombosis, drug-drug interactions with anticoagulants, and obesity-related thromboembolism. She holds a Tier 2 Clinical Research Chair in Cancer and Thromboembolism from the University of Ottawa. She has received research funding from the International Society on Thrombosis and Haemostasis (ISTH), the Canadian Institutes of Health Research (CIHR), The Ottawa Hospital Academic Medical Organization (TOHAMO), and the International Network of VENous Thromboembolism Clinical Research Networks (INVENT). She is currently the Chair of the ISTH (International Society on Thrombosis and Haemostasis) Live Courses Subcommittee of the Education Committee. She was a co-chair of the Hemostasis and Malignancy Subcommittee of the International Society on Thrombosis and Haemostasis from 2018 to 2022.
Research Goals and Interests
News
Publications
Recurrent VTE in patients with thrombophilia after stopping anticoagulation - A systematic review and meta-analysis
2026-07-14 Go to publicationBiomarkers, association, and prediction in cancer-associated thrombosis and bleeding
2026-06-29 Go to publicationThe association between patient preferred language and end-of-life outcomes of home care patients who died from a cancer in Ontario, Canada – A retrospective cohort study
2026-06-22 Go to publicationEffect of PCC on Thrombin Generation in Patients on FXaI with Bleeding or Needing Urgent Surgery (GAUGE)
2026-06-11 Go to publicationIntracranial hemorrhage in patients with primary brain cancer receiving anticoagulation
2026-05-01 Go to publication